Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Schizophr Res ; 99(1-3): 134-8, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18155881

RESUMO

We aimed to evaluate suicide risk across the life-course in severe mental illnesses (SMI) including schizophrenia. Using survival analysis, we compared suicide risk in cohorts of 46,136 people with SMI and 300,426 without. The overall unadjusted hazard ratio (HR) for suicide in SMI was 12.97 (95% CI: 9.75-17.25). The unadjusted HRs differed by age band: 18-30 years: 19.56 (9.76-39.17); 30-50 years: 13.14 (8.64-19.99); 50-70 years: 16.39 (9.15-29.37); 70+: 3.25 (1.33-7.94). In schizophrenia, risk was significantly higher when young but marked risk persisted until age 70. Greatest risk was associated with: increased consultation rates; antidepressant prescriptions and living in less deprived areas.


Assuntos
Transtorno Bipolar/mortalidade , Transtornos Psicóticos/mortalidade , Esquizofrenia/mortalidade , Psicologia do Esquizofrênico , Suicídio/estatística & dados numéricos , Adolescente , Adulto , Idoso , Antidepressivos/efeitos adversos , Antidepressivos/uso terapêutico , Transtorno Bipolar/diagnóstico , Transtorno Bipolar/psicologia , Estudos de Coortes , Medicina de Família e Comunidade , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Modelos de Riscos Proporcionais , Carência Psicossocial , Transtornos Psicóticos/diagnóstico , Transtornos Psicóticos/psicologia , Encaminhamento e Consulta/estatística & dados numéricos , Risco , Esquizofrenia/diagnóstico , Suicídio/psicologia , Análise de Sobrevida , Reino Unido , Revisão da Utilização de Recursos de Saúde/estatística & dados numéricos
2.
Arch Gen Psychiatry ; 64(2): 242-9, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17283292

RESUMO

CONTEXT: People with severe mental illness (SMI) appear to have an elevated risk of death from cardiovascular disease, but results regarding cancer mortality are conflicting. OBJECTIVE: To estimate this excess mortality and the contribution of antipsychotic medication, smoking, and social deprivation. DESIGN: Retrospective cohort study. SETTING: United Kingdom's General Practice Research Database. Patients Two cohorts were compared: people with SMI diagnoses and people without such diagnoses. Main Outcome Measure Mortality rates for coronary heart disease (CHD), stroke, and the 7 most common cancers in the United Kingdom. RESULTS: A total of 46 136 people with SMI and 300 426 without SMI were selected for the study. Hazard ratios (HRs) for CHD mortality in people with SMI compared with controls were 3.22 (95% confidence interval [CI], 1.99-5.21) for people 18 through 49 years old, 1.86 (95% CI, 1.63-2.12) for those 50 through 75 years old, and 1.05 (95% CI, 0.92-1.19) for those older than 75 years. For stroke deaths, the HRs were 2.53 (95% CI, 0.99-6.47) for those younger than 50 years, 1.89 (95% CI, 1.50-2.38) for those 50 through 75 years old, and 1.34 (95% CI, 1.17-1.54) for those older than 75 years. The only significant result for cancer deaths was an unadjusted HR for respiratory tumors of 1.32 (95% CI, 1.04-1.68) for those 50 to 75 years old, which lost statistical significance after controlling for smoking and social deprivation. Increased HRs for CHD mortality occurred irrespective of sex, SMI diagnosis, or prescription of antipsychotic medication during follow-up. However, a higher prescribed dose of antipsychotics predicted greater risk of mortality from CHD and stroke. CONCLUSIONS: This large community sample demonstrates that people with SMI have an increased risk of death from CHD and stroke that is not wholly explained by antipsychotic medication, smoking, or social deprivation scores. Rates of nonrespiratory cancer mortality were not raised. Further research is required concerning prevention of this mortality, including cardiovascular risk assessment, monitoring of antipsychotic medication, and attention to diet and exercise.


Assuntos
Doenças Cardiovasculares/mortalidade , Medicina de Família e Comunidade/estatística & dados numéricos , Transtornos Mentais/mortalidade , Neoplasias/mortalidade , Adolescente , Adulto , Distribuição por Idade , Idoso , Antipsicóticos/efeitos adversos , Antipsicóticos/uso terapêutico , Doenças Cardiovasculares/epidemiologia , Causas de Morte , Estudos de Coortes , Comorbidade , Doença das Coronárias/epidemiologia , Doença das Coronárias/mortalidade , Bases de Dados como Assunto/estatística & dados numéricos , Feminino , Humanos , Masculino , Transtornos Mentais/diagnóstico , Transtornos Mentais/epidemiologia , Pessoa de Meia-Idade , Mortalidade , Neoplasias/epidemiologia , Modelos de Riscos Proporcionais , Risco , Índice de Gravidade de Doença , Fumar/efeitos adversos , Fumar/epidemiologia , Fumar/psicologia , Isolamento Social/psicologia , Acidente Vascular Cerebral/epidemiologia , Acidente Vascular Cerebral/mortalidade , Reino Unido/epidemiologia
3.
BMC Psychiatry ; 8: 84, 2008 Sep 25.
Artigo em Inglês | MEDLINE | ID: mdl-18817565

RESUMO

BACKGROUND: Severe mental illnesses (SMI) may be independently associated with cardiovascular risk factors and the metabolic syndrome. We aimed to systematically assess studies that compared diabetes, dyslipidaemia, hypertension and metabolic syndrome in people with and without SMI. METHODS: We systematically searched MEDLINE, EMBASE, CINAHL & PsycINFO. We hand searched reference lists of key articles. We employed three search main themes: SMI, cardiovascular disease, and each cardiovascular risk factor. We selected cross-sectional, case control, cohort or intervention studies comparing one or more risk factor in both SMI and a reference group. We excluded studies without any reference group. We extracted data on: study design, cardiovascular risk factor(s) and their measurement, diagnosis of SMI, study setting, sampling method, nature of comparison group and data on key risk factors. RESULTS: Of 14592 citations, 134 papers met criteria and 36 were finally included. 26 reported on diabetes, 12 hypertension, 11 dyslipidaemia, and 4 metabolic syndrome. Most studies were cross sectional, small and several lacked comparison data suitable for extraction. Meta-analysis was possible for diabetes, cholesterol and hypertension; revealing a pooled risk ratio of 1.70 (1.21 to 2.37) for diabetes and 1.11 (0.91 to 1.35) of hypertension. Restricting SMI to schizophreniform illnesses yielded a pooled risk ratio for diabetes of 1.87 (1.68 to 2.09). Total cholesterol was not higher in people with SMI (Standardized Mean Difference -0.10 (-0.55 to 0.36)) and there were inconsistent data on HDL, LDL and triglycerides with some, but not all, reporting lower levels of HDL cholesterol and raised triglyceride levels. Metabolic syndrome appeared more common in SMI. CONCLUSION: Diabetes (but not hypertension) is more common in SMI. Data on other risk factors were limited by poor quality or inconsistent research findings, but a small number of studies show greater prevalence of the metabolic syndrome in SMI.


Assuntos
Diabetes Mellitus/epidemiologia , Dislipidemias/epidemiologia , Hipertensão/epidemiologia , Transtornos Mentais/epidemiologia , Síndrome Metabólica/epidemiologia , Comorbidade , Humanos , Prevalência , Fatores de Risco
4.
Br J Psychiatry ; 192(5): 362-7, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18450661

RESUMO

BACKGROUND: There is evidence that the prevalence of common mental disorders varies across Europe. AIMS: To compare prevalence of common mental disorders in general practice attendees in six European countries. METHOD: Unselected attendees to general practices in the UK, Spain, Portugal, Slovenia, Estonia and The Netherlands were assessed for major depression, panic syndrome and other anxiety syndrome. Prevalence of DSM-IV major depression, other anxiety syndrome and panic syndrome was compared between the UK and other countries after taking account of differences in demographic factors and practice consultation rates. RESULTS: Prevalence was estimated in 2,344 men and 4,865 women. The highest prevalence for all disorders occurred in the UK and Spain, and lowest in Slovenia and The Netherlands. Men aged 30-50 and women aged 18-30 had the highest prevalence of major depression; men aged 40-60 had the highest prevalence of anxiety, and men and women aged 40-50 had the highest prevalence of panic syndrome. Demographic factors accounted for the variance between the UK and Spain but otherwise had little impact on the significance of observed country differences. CONCLUSIONS: These results add to the evidence for real differences between European countries in prevalence of psychological disorders and show that the burden of care on general practitioners varies markedly between countries.


Assuntos
Transtornos de Ansiedade/epidemiologia , Transtorno Depressivo Maior/epidemiologia , Medicina de Família e Comunidade/estatística & dados numéricos , Adolescente , Adulto , Idoso , Comparação Transcultural , Demografia , Europa (Continente)/epidemiologia , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Transtorno de Pânico/epidemiologia , Prevalência , Escalas de Graduação Psiquiátrica , Encaminhamento e Consulta/estatística & dados numéricos
5.
Arch Gen Psychiatry ; 65(12): 1368-76, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19047523

RESUMO

CONTEXT: Strategies for prevention of depression are hindered by lack of evidence about the combined predictive effect of known risk factors. OBJECTIVES: To develop a risk algorithm for onset of major depression. DESIGN: Cohort of adult general practice attendees followed up at 6 and 12 months. We measured 39 known risk factors to construct a risk model for onset of major depression using stepwise logistic regression. We corrected the model for overfitting and tested it in an external population. SETTING: General practices in 6 European countries and in Chile. PARTICIPANTS: In Europe and Chile, 10 045 attendees were recruited April 2003 to February 2005. The algorithm was developed in 5216 European attendees who were not depressed at recruitment and had follow-up data on depression status. It was tested in 1732 patients in Chile who were not depressed at recruitment. Main Outcome Measure DSM-IV major depression. RESULTS: Sixty-six percent of people approached participated, of whom 89.5% participated again at 6 months and 85.9%, at 12 months. Nine of the 10 factors in the risk algorithm were age, sex, educational level achieved, results of lifetime screen for depression, family history of psychological difficulties, physical health and mental health subscale scores on the Short Form 12, unsupported difficulties in paid or unpaid work, and experiences of discrimination. Country was the tenth factor. The algorithm's average C index across countries was 0.790 (95% confidence interval [CI], 0.767-0.813). Effect size for difference in predicted log odds of depression between European attendees who became depressed and those who did not was 1.28 (95% CI, 1.17-1.40). Application of the algorithm in Chilean attendees resulted in a C index of 0.710 (95% CI, 0.670-0.749). CONCLUSION: This first risk algorithm for onset of major depression functions as well as similar risk algorithms for cardiovascular events and may be useful in prevention of depression.


Assuntos
Algoritmos , Transtorno Depressivo Maior/diagnóstico , Transtorno Depressivo Maior/epidemiologia , Medicina de Família e Comunidade/estatística & dados numéricos , Medicina de Família e Comunidade/normas , Adolescente , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Medição de Risco
6.
Alcohol Alcohol ; 42(2): 131-7, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17172257

RESUMO

AIMS: To determine (i) the prevalence and characteristics of harmful alcohol consumption in general practice attendees; (ii) social and psychological associations with harmful drinking and (iii) recognition of harmful drinking by GPs. METHODS: A cross-sectional study of ten general practices in Goa, India. A total of 1567 general practice attendees were recruited. RESULTS: A total of 338 men (41%) and 597 women (81%) reported that they never consumed alcohol. One hundred and twenty-eight people or 8.2% scored >or=8 on the AUDIT [123 (15%) men and five (0.7%) women] and were classified as harmful or dependent drinkers. The population attributable fraction of harmful drinking in the perpetration of any physical violence by men over 12 months was 0.36. The population attributable fraction of moderate drinking (vs abstention) in the perpetration of any physical violence by women over 12 months was 0.27. Doctors identified almost 60% of problem drinkers but misidentified approximately 5% of moderate drinkers as problem drinkers. CONCLUSIONS: The male pattern of drinking in Goa is one of the high rates of abstention coupled with relatively high rates of harmful and dependent drinking in those who consume alcohol. Most women are abstainers. These data provide the first evidence in India on (i) the role of the GP in identification of harmful alcohol use and (ii) the contribution of harmful drinking to the perpetration of physical violence from the perspective of the alcohol user.


Assuntos
Alcoolismo/epidemiologia , Comparação Transcultural , Países em Desenvolvimento , Violência/estatística & dados numéricos , Adulto , Idoso , Consumo de Bebidas Alcoólicas/efeitos adversos , Consumo de Bebidas Alcoólicas/epidemiologia , Alcoolismo/diagnóstico , Alcoolismo/psicologia , Comorbidade , Estudos Transversais , Medicina de Família e Comunidade/estatística & dados numéricos , Feminino , Inquéritos Epidemiológicos , Humanos , Índia , Masculino , Programas de Rastreamento/estatística & dados numéricos , Pessoa de Meia-Idade , Fatores Sexuais , Fumar/epidemiologia , Fatores Socioeconômicos , Violência/psicologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA